Allscripts Healthcare Solutions

Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segments. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, and Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.

Earnings data Q4 2019

Earnings data Q1 2020

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Allscripts' (MDRX) revenue growth in the fourth quarter is likely to have been boosted by solid segmental performances.

Allscripts (MDRX) Reports Solid Preliminary Q4 Revenues

Here is how AllScripts Healthcare (MDRX) and Pharvaris N.V. (PHVS) have performed compared to their sector so far this year.

Is AllScripts Healthcare (MDRX) Outperforming Other Medical Stocks This Year?

If the company's latest set of preliminary results is any indication, it had a far better than expected Q4 and full-year 2021.

Why Allscripts Stock Blasted 16% Higher Today

The stock price of Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) increased by over 14% during intraday trading today. This is why it happened.

Allscripts Stock (MDRX): Why The Price Substantially Went Up Today

Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) expects Q4 revenue of $390 million - $395 million, better than the consensus of $$386.75 million. For FY21, the Company expects GAAP operating income of $70 million - $75 million and adjusted EBITDA of $295 million - $300 million, an increase from the prior outlook of $275 million - $285 million.

Allscripts Expects Q4 Interim Sales Beat Consensus; Approves $250M Buyback

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) today announced preliminary financial results for the three and twelve months ended December 31, 2021. Revenue for the fourth quarter of 2021 is expected to be between $390 million and $395 million. For the full year 2021, the company expects GAAP operating income to be between $70 million and $75 million and expects Adjusted EBITDA(1) to be between $295 million and $300 million, an increase from the pri

Allscripts Announces Preliminary Fourth Quarter and Fiscal Year 2021 Results and New Share Repurchase Program

Allscripts' (MDRX) Touchworks platform and Microsoft Azure hosting & services will be implemented across all Next Level Urgent Care's sites in Houston.

Allscripts' (MDRX) Services Leveraged by Next Level Urgent Care

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) announced today that Next Level Urgent Care has selected Allscripts to improve connectivity, provide better electronic health record (EHR) workflows and greatly advance analytics to all of its locations. All Next Level Urgent Care's facilities will implement Allscripts Touchworks® platform as well as Microsoft Azure hosting and services. Next Level Urgent Care provides walk-in care for non-life-threatening illnesses and injuries such as sprain

Next Level Urgent Care Selects Allscripts to Help Drive Clinical, Financial and Operational Performance

Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q3 2021 Results - Earnings Call Transcript

Allscripts' (MDRX) robust Q3 results demonstrate strength in both segments.

Allscripts' (MDRX) Q3 Earnings Beat Estimates, Margins Up

AllScripts (MDRX) delivered earnings and revenue surprises of 50.00% and -1.91%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

AllScripts Healthcare (MDRX) Q3 Earnings Surpass Estimates

CHICAGO--(BUSINESS WIRE)---- $MDRX--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and nine months ended September 30, 2021. Bookings(1) were $166 million in the third quarter of 2021. This result compares with $160 million in the third quarter of 2020. Contract revenue backlog totaled $3.9 billion as of September 30, 2021. Third quarter 2021 revenue was $369 million compared with $366 million in the third quarter of 2020. On a GAAP basis i

Allscripts Announces Third Quarter 2021 Results

CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months ended September 30, 2021 after the close of stock market hours on Thursday, November 4, 2021. Allscripts management plans to host a conference call and webcast to discuss the company's earnings at 4:30 p.m. Eastern Time that same day. Third-Quarter 2021 Financial Results Call Details The Allscripts earnings announcement will be distributed immediately after the cl

Allscripts to Release Third-Quarter 2021 Financial Results November 4

Allscripts' (MDRX) latest AI-based scheduling application is expected to provide improved patient care as well as increase operational efficiencies of the healthcare system.

Allscripts' (MDRX) New AI-Based Offering to Improve Patient Care

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ MDRX) Guided Scheduling, launching in Allscripts Practice Management, is an artificial intelligence scheduling application that uses real-time provider, practice, and industry data to optimize providers' days. The system looks at key clinical and operational metrics, allowing users to appropriately schedule each patient visit. Allscripts Guided Scheduling can result in the increased speed of high-need patients receiving care, the improved utilization

Allscripts Launches Guided Scheduling, Leveraging Artificial Intelligence to Improve Patient Care and Increase Healthcare Operational Efficiencies

Phreesia Inc

PHILADELPHIA--(BUSINESS WIRE)--Seminal Capital Holdings, LLC ("SEMCAP") announces the appointments of Victor Kats (Managing Partner), Mark Miller (Managing Director) and Lindsey Watson (Managing Director – Portfolio Impact) to its Seminal Healthcare team. These latest additions further differentiate Seminal Healthcare's deep healthcare investing experience and team, which includes an active network of leading Senior Operating Advisors who represent some of the most influential leaders in health

SEMCAP's Seminal Healthcare Expands its Investment Team, including Victor Kats as a Managing Partner

Allscripts' (MDRX) Veradigm enters collaboration with CareMetx to streamline specialty medication management for medical clinics and practices across the nation.

Allscripts (MDRX), CareMetx Tie Up for Better Patient Care

CHICAGO--(BUSINESS WIRE)--Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new agreement for CareMetx to integrate its solutions and services directly into the Veradigm AccelRx® specialty medication platform. The agreement will make Veradigm's AccelRx automat

Veradigm Partners with CareMetx, LLC to Optimize End-to-End Specialty Medication Access and Services Streamlining Patient Care

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) is pleased to have been selected as one of Eastern Health's innovation partners. As a result, Allscripts and Eastern Health have partnered to advance health-care services and programs while maximizing health system efficiencies and general economic development in Newfoundland and Labrador. The goal of this partnership is to improve health care and better serve its patients and their family members. Eastern Health is the largest health authorit

Eastern Health Selects Allscripts as One of Its Partners to Further Healthcare Innovation

CHICAGO--(BUSINESS WIRE)--Allscripts (NASDAQ: MDRX) recently hosted its Advancing Health Equity Using Social Determinants of Health Developer Challenge in an effort to elevate solutions that use technology to share relevant social determinants of health patient information with care providers. Access to patients' social determinants of health (SDOH) information is crucial in advancing health equity across patient populations—especially at a time when equitable access to healthcare is more impor

Allscripts hosts Developer Challenge: Advancing Health Equity Using Social Determinants of Health

Allscripts' (MDRX) robust Q2 results demonstrate its strength in Client services segment.

Allscripts' (MDRX) Shares Up Following Q2 Earnings Beat

Allscripts Healthcare Solutions, Inc. (MDRX) CEO Paul Black on Q2 2021 Results - Earnings Call Transcript

AllScripts (MDRX) delivered earnings and revenue surprises of 27.78% and 0.32%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

AllScripts Healthcare (MDRX) Surpasses Q2 Earnings and Revenue Estimates

CHICAGO--(BUSINESS WIRE)---- $MDRX #healthIT--Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three and six months ended June 30, 2021. Bookings(1) were $180 million in the second quarter of 2021. This result compares with $164 million in the second quarter of 2020. Contract revenue backlog totaled $3.9 billion as of June 30, 2021. Second quarter 2021 revenue was $374 million compared with $369 million in the second quarter of 2020. On a GAAP basis in the s

Allscripts Announces Second Quarter 2021 Results

AllScripts (MDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for Allscripts Healthcare Solutions Stock (MDRX)